Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Liabilities and Shareholders Equity: 2020-2024

Historic Liabilities and Shareholders Equity for Core Scientific (CORZ) over the last 5 years, with Dec 2024 value amounting to $1.6 billion.

  • Core Scientific's Liabilities and Shareholders Equity rose 149.06% to $2.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 billion, marking a year-over-year increase of 133.63%. This contributed to the annual value of $1.6 billion for FY2024, which is 124.50% up from last year.
  • Per Core Scientific's latest filing, its Liabilities and Shareholders Equity stood at $1.6 billion for FY2024, which was up 124.50% from $712.2 million recorded in FY2023.
  • In the past 5 years, Core Scientific's Liabilities and Shareholders Equity ranged from a high of $2.4 billion in FY2021 and a low of $15,000 during FY2020.
  • For the 3-year period, Core Scientific's Liabilities and Shareholders Equity averaged around $1.0 billion, with its median value being $807.7 million (2022).
  • As far as peak fluctuations go, Core Scientific's Liabilities and Shareholders Equity spiked by 16,258,993.33% in 2021, and later slumped by 66.88% in 2022.
  • Core Scientific's Liabilities and Shareholders Equity (Yearly) stood at $15,000 in 2020, then spiked by 16,258,993.33% to $2.4 billion in 2021, then plummeted by 66.88% to $807.7 million in 2022, then dropped by 11.83% to $712.2 million in 2023, then soared by 124.50% to $1.6 billion in 2024.